Atrasentan Enantiomer | CAS 173864-34-1 - Request Quote
Atrasentan Enantiomer
| SZ CAT No: | SZ-A221010 |
| CAS No | 173864-34-1 |
| Mol.F. | C29H38N2O6 |
| Mol.Wt. |
510.6 |
| Inv. Status |
|
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Atrasentan Enantiomer is chemically (2S,3S,4R)-4-(benzo[d][1,3]dioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid. Atrasentan Enantiomer is supplied with detailed characterization data compliant with regulatory guideline. Atrasentan Enantiomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atrasentan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 173864-34-1
Purchase 173864-34-1
Order 173864-34-1
Enquire 173864-34-1
price of 173864-34-1
173864-34-1 Supplier
173864-34-1 Manufacturer
173864-34-1 Exporter
buy high quality Atrasentan Enantiomer
Purchase Atrasentan Enantiomer
Atrasentan Enantiomer suppliers
Atrasentan Enantiomer manufacturers
Atrasentan Enantiomer price
Order Atrasentan Enantiomer
Enquire Atrasentan Enantiomer
Atrasentan Enantiomer cost
Atrasentan Enantiomer Supplier
Atrasentan Enantiomer Distributor
Atrasentan Enantiomer for Method Validation
Atrasentan Reference Standard
Atrasentan Enantiomer for ANDA Filing
Atrasentan Enantiomer for Forced Degradation Studies
Atrasentan Enantiomer Identification Standards
Atrasentan Enantiomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.